Fear of cancer recurrence in prostate cancer survivors

Acta Oncologica

Volumn 55, Issue 7, 2016, Pages 821-827

  van de Wal, Marieke ^a   van Oort, Inge ^a   Schouten, Joost ^a   Thewes, Belinda ^a   Gielissen, Marieke ^a   Prins, Judith ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN;

ADJUVANT RADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVOR; CANCER WORRY SCALE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DISTRESS SYNDROME; FEAR; FEAR OF CANCER RECURRENCE; FEAR OF CANCER RECURRENCE INVENTORY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; ADENOCARCINOMA; DIAGNOSIS; PATHOLOGY; PHOBIC DISORDERS; PROSTATIC NEOPLASMS; PSYCHOLOGY; SURVIVOR; TUMOR RECURRENCE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEAR; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOBIC DISORDERS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; SURVIVORS;

EID: 84975126927     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2016.1150607     Document Type: Article

References (25)

1. S.M.Vickberg The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med 2003;25:16–24.
2. S.Simard, J.Savard Fear of Cancer Recurrence Inventory: Development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 2009;17:241–51.
3. C.Lee-Jones, G.Humphris, R.Dixon, M.Bebbington Hatcher Fear of cancer recurrence — a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology 1997;6:95–105.
4. A.Mehnert, P.Berg, G.Henrich, P.Herschbach Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology 2009;18:1273–80.
5. S.Lebel, C.Tomei, A.Feldstain, S.Beattie, M.McCallum Does fear of cancer recurrence predict cancer survivors' health care use? Support Care Cancer 2013;21:901
6. S.Simard, B.Thewes, G.Humphris, M.Dixon, C.Hayden, S.Mireskandari, et al. Fear of cancer recurrence in adult cancer survivors: A systematic review of quantitative studies. J Cancer Surviv 2013;7:1–23.
7. L.Koch, L.Jansen, H.Brenner, V.Arndt Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors-a systematic review of quantitative studies. Psychooncology 2013; 22:1–11.
8. S.L.Hart, D.M.Latini, J.E.Cowan Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer 2008;16:161
9. K.M.Bellizzi, D.M.Latini, J.E.Cowan, J.DuChane, P.R.Carroll Fear of recurrence, symptom Burden, and health-related quality of life in men with prostate cancer. Urology 2008;72:1269–73.
10. Y.M.Hong, J.C.Hu, A.T.Paciorek, S.J.Knight, P.R.Carroll Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: results from CaPSURE. Urol Oncol 2010;28:268–73.
11. S.S.Mehta, D.P.Lubeck, D.J.Pasta, M.S.Litwin Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE. J Urol 2003;170:1931–3.
12. S.Simard, J.Savard Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv 2015;9:481–91.
13. Integraal Kankercentrum Nederland (IKNL). Cijfers over kanker [Internet]. [Place unknown]: IKNL; 2011 [cited 2015 June 27]. Available from: http://www.cijfersoverkanker.nl.
14. B.Thewes, M.L.Bell, P.Butow Fear of cancer recurrence in young early-stage breast cancer survivors: The role of metacognitive style and disease-related factors. Psychooncology 2013;22:2059–63.
15. J.A.Custers, S.W.van den Berg, H.W.van Laarhoven, E.M.Bleiker, M.F.Gielissen, J.B.Prins The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors. Cancer Nurs 2014;37:E44–50.
16. A.Roth, C.J.Nelson, B.Rosenfeld, A.Warshowski, N.O'shea, H.Scher, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the memorial anxiety scale for prostate cancer (MAX–PC). Psychosomatics 2006;47:340–7.
17. A.S.Zigmond, R.P.Snaith The hospital anxiety and depression scale. Acta Psychiatr 1983;67:361–70.
18. M.Horowitz, N.Wilner, W.Alvarez Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979;41:209–18.
19. N.K.Aaronson, S.Ahmedzai, B.Bergman, M.Bullinger, A.Cull, N.J.Duez, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76.
20. G.van Andel, A.Bottomley, S.D.Fosså, F.Efficace, C.Coens, S.Guerif, et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer 2008;44:2418–24.
21. P.M.Fayers, N.K.Aaronson, K.Bjordal, M.Groenvold, D.Curran, A.Bottomley on behalf of the EORTC Quality of Life Group. The EORTC QLQ-C30 Scoring Manual (3rd Edition). Published by: European Organisation for Research and Treatment of Cancer, Brussels 2001.
22. J.A.Custers, M.F.M.Gielissen, S.H.V.Janssen, J.H.W.de Wilt, J.B.Prins Fear of cancer recurrence in colorectal cancer survivors. Support Care Cancer 2016;24:555–62.
23. M.Ozga, C.Aghajanian, S.Myers-Virtue, G.McDonnell, S.Jhanwar, S.Hichenberg, et al. A systematic review of ovarian cancer and fear of recurrence. Palliat Support Care 2015;13:1771–80.
24. P.M.Ullrich, M.R.Carson, S.K.Lutgendorf Cancer fear and mood disturbance after radical prostatectomy: consequences of biochemical evidence of recurrence. J Urol 2003;169:1449–52.
25. E.B.Lamont, M.B.Landrum, N.L.Keating, L.Archer, L.Lan, G.M.Strauss, et al. Differences in clinical trial patient attributes and outcomes according to enrollment setting. J Clin Oncol 2010;28:215–21.